secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K/A
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0000950170-25-096923
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics amends 8-K to disclose up to 41.4M shares issuable under SEPA with YA II PN
--------------------------------------------------------------------------------

- Maximum shares convertible from $15M promissory notes: 36,945,812 shares at $0.406/share.
- Additional maximum shares from Commitment Amount: 4,424,778 shares at $2.26/share.
- Agreement with YA II PN, Ltd. was previously disclosed on Dec 20, 2024; amendment adds share counts.
- Conversion price subject to anti-dilution adjustments; shares unregistered under Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025096923/0000950170-25-096923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025096923/fblg-20241220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-096923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer